Wikipedia -WSS

Wikipedia

author：focus 2025-08-26 23:44:44 - browse：5

Eli Lilly headquarters — Kristoffer Tripplaar/AP

The drug giant Eli Lilly said Thursday that its diabetes drug Mounjaro helped patients with the condition lose 15.7% of their body weight in a clinical trial, a result that Wall Street analysts expect to pave the way for the therapy’s approval as a weight loss treatment.

Mounjaro is the latest drug in a class known as GLP-1s or incretins — the same class as Novo Nordisk’s Ozempic, which has become a sensation because of its ability to help patients lose weight. Mounjaro has shown the potential to lead to even greater weight loss than Ozempic, and industry experts expect that it will eventually generate many billions of dollars in annual sales. Analysts at SVB Securities projected in December that Mounjaro sales could reach $26.4 billion by 2030.

Eli Lilly on Thursday also announced quarterly earnings of $1.64 per share, adjusted for one-time items, slightly below analyst expectations, on sales of $6.96 billion. Sales were hurt because of a comparison to a year ago, when the company’s Covid-19 monoclonal antibodies were still on the market. Mounjaro sales for the first quarter were $586 million, largely for people with diabetes, compared to an analyst consensus of $433.2 million.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The high cost of giving birth even with insurance
Next article： How to address the problem of discarded donor organs

leisure time

WSS

An inside look at PIPEs, biotech's buzzy new financing tool

Ancient Greek ideas underpin modern concepts of pregnancy

Readout LOUD Podcast: Legal insider trading, booming biotech stocks

Medicare drug price negotiation hearing pits pharma v Biden admin

Kenai launches with $82 million for Parkinson’s stem cell therapy

Lack of health data on LGBTQ+ people has serious consequences

explore

Wikipedia

focus

Medicare proposal to cover medical devices draws a mixed reaction

Obesity now affects over 1 billion people worldwide, study finds

Drug repurposing or repositioning? The language matters

Clinical trials giant ICON acquires HumanFirst

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

ALS groups 'won't be played again' by the FDA, drug sponsors

Medical records are filled with copy

Pregnant women don't need prenatal multivitamins, study concludes

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Obesity now affects over 1 billion people worldwide, study finds

hotspot

Readout Newsletter: BridgeBio, Akero, and human embryo models

Medicare drug price negotiation continues, as pharma counteroffers

RaDonda Vaught to speak at CommonSpirit event on patient safety

ALS groups 'won't be played again' by the FDA, drug sponsors

Pregnant women don't need prenatal multivitamins, study concludes

Biotech companies concerned about China biosecurity crackdown

focus

entertainment

leisure time

hotspot